NCT00280085终止不适用
Pancreatic Beta-Cell Mass And Function Quantification By Means Of Perfusion Imaging
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- Pfizer
- 入组人数
- 29
- 试验地点
- 2
- 主要终点
- Pancreatic perfusion
研究概览
简要总结
Assess pancreatic beta cell function using MR imaging.
详细描述
The study was terminated on July 31st, 2007. The study was discontinued, as we have not met the primary end point, differentiation between normal volunteers and subjects with type 1 diabetes mellitus. There were no safety concerns.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Normal Volunteers
- •T1DM and T2DM subjects
排除标准
- •Concomitant severe conditions
结局指标
主要结局
Pancreatic perfusion
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Assessment of Beta Cell Mass by PET Scans With [11C] Dihydrotetrabenazine (DTBZ) in Longstanding Type 1 Diabetes.Type 1 DiabetesNCT00738907National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)18
已完成
不适用
PET Scan Imaging of Beta Cell MassObesityType 1 DiabetesNCT00771576Columbia University30
已完成
不适用
Positron Emission Tomography (PET) Imaging of Pancreatic Beta-Cell Mass in Healthy and Type 1 Diabetic PatientsDiabetes Mellitus, Type 1NCT00958997Yale University16
招募中
不适用
Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes MellitusPre DiabetesNCT05662189Azienda Ospedaliero-Universitaria di Parma70
已完成
不适用
Immune Biomarkers of Residual Beta-cell Mass in Type 1 DiabetesType 1 DiabetesNCT01747967Assistance Publique - Hôpitaux de Paris156